D-Index & Metrics Best Publications
Medicine
Denmark
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 95 Citations 26,585 310 World Ranking 6227 National Ranking 63

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Denmark Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Endocrinology

The scientist’s investigation covers issues in Internal medicine, Endocrinology, Surgery, Risk factor and Osteoporosis. Internal medicine is closely attributed to Placebo in his research. The study incorporates disciplines such as Cortical bone, Calcium metabolism and Parathyroid hormone in addition to Endocrinology.

In his study, Forearm is strongly linked to Cohort study, which falls under the umbrella field of Surgery. The Risk factor study combines topics in areas such as Odds ratio, Relative risk, Blood pressure, Atrial fibrillation and Type 2 diabetes. His Osteoporosis research is multidisciplinary, incorporating perspectives in Hormone replacement therapy, Age related and Vertebral body.

His most cited work include:

  • Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. (454 citations)
  • Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry (395 citations)
  • Vitamin D and the elderly (339 citations)

What are the main themes of his work throughout his whole career to date?

Leif Mosekilde mainly focuses on Internal medicine, Endocrinology, Osteoporosis, Surgery and Vitamin D and neurology. His work on Placebo expands to the thematically related Internal medicine. His work carried out in the field of Endocrinology brings together such families of science as Calcium metabolism, Parathyroid hormone and Osteocalcin.

His Osteoporosis research is multidisciplinary, relying on both Physical therapy, Menopause and Raloxifene. His studies in Surgery integrate themes in fields like Relative risk, Case-control study, Cohort study and Risk factor. His Vitamin D and neurology study combines topics from a wide range of disciplines, such as Vitamin and Secondary hyperparathyroidism.

He most often published in these fields:

  • Internal medicine (69.07%)
  • Endocrinology (46.39%)
  • Osteoporosis (21.31%)

What were the highlights of his more recent work (between 2012-2019)?

  • Internal medicine (69.07%)
  • Endocrinology (46.39%)
  • Vitamin D and neurology (16.49%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Internal medicine, Endocrinology, Vitamin D and neurology, Hypoparathyroidism and Placebo. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Surgery. The various areas that Leif Mosekilde examines in his Endocrinology study include Calcium metabolism, Parathyroid hormone and Familial hypocalciuric hypercalcemia.

His Vitamin D and neurology research incorporates themes from Vitamin, Myocardial infarction and Animal science. Leif Mosekilde has researched Hypoparathyroidism in several fields, including Postural stability and Epidemiology. His studies examine the connections between Placebo and genetics, as well as such issues in Leptin, with regards to Osteocalcin and Weight loss.

Between 2012 and 2019, his most popular works were:

  • Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. (145 citations)
  • Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. (129 citations)
  • Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections. (110 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cancer

Leif Mosekilde focuses on Internal medicine, Endocrinology, Hypoparathyroidism, Placebo and Vitamin D and neurology. His Methylmalonic acid study in the realm of Internal medicine interacts with subjects such as Trustworthiness. His Hypoparathyroidism study combines topics in areas such as Quality of life, Parathyroid hormone and Pediatrics.

Leif Mosekilde focuses mostly in the field of Placebo, narrowing it down to matters related to Randomized controlled trial and, in some cases, Relative risk, Angina, Meta-analysis and Physical therapy. His biological study spans a wide range of topics, including Myocardial infarction, Acute coronary syndrome, Vitamin and Cohort study. The Bone remodeling study which covers Osteoporosis that intersects with Orthopedic surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

Louise Lind Schierbeck;Lars Rejnmark;Charlotte Landbo Tofteng;Lis Stilgren.
BMJ (2012)

772 Citations

Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk

P. Vestergaard;L. Rejnmark;L. Mosekilde.
Diabetologia (2005)

665 Citations

Effects of thyroid hormones on bone and mineral metabolism.

Leif Mosekilde;Erik Fink Eriksen;Peder Charles.
Endocrinology and Metabolism Clinics of North America (1990)

585 Citations

Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research

John P Bilezikian;Aliya Khan;John T Potts;Maria Luisa Brandi.
Journal of Bone and Mineral Research (2011)

547 Citations

Vitamin D and the elderly

Leif Mosekilde.
Clinical Endocrinology (2005)

539 Citations

Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis.

T. Hagenau;R. Vest;T. N. Gissel;C. S. Poulsen.
Osteoporosis International (2009)

531 Citations

Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.

Erik F. Eriksen;Peder Charles;Flemming Melsen;Leif Mosekilde.
Journal of Bone and Mineral Research (2009)

520 Citations

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.

P. Vestergaard;L. Rejnmark;L. Mosekilde.
Calcified Tissue International (2006)

493 Citations

Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study.

Erik Roj Larsen;Leif Mosekilde;Anders Foldspang.
Journal of Bone and Mineral Research (2003)

451 Citations

Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers

Ellen M. Hauge;Dorte Qvesel;Erik Fink Eriksen;Leif Mosekilde.
Journal of Bone and Mineral Research (2001)

450 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Leif Mosekilde

Lars Rejnmark

Lars Rejnmark

Aarhus University

Publications: 106

John P. Bilezikian

John P. Bilezikian

Columbia University

Publications: 103

Peter Vestergaard

Peter Vestergaard

Steno Diabetes Center

Publications: 99

Kim Brixen

Kim Brixen

University of Southern Denmark

Publications: 76

Moustapha Kassem

Moustapha Kassem

University of Southern Denmark

Publications: 74

Cyrus Cooper

Cyrus Cooper

University of Southampton

Publications: 73

Erik Fink Eriksen

Erik Fink Eriksen

University of Oslo

Publications: 55

Ego Seeman

Ego Seeman

University of Melbourne

Publications: 41

Shonni J. Silverberg

Shonni J. Silverberg

Columbia University

Publications: 41

Richard Eastell

Richard Eastell

University of Sheffield

Publications: 40

William D. Leslie

William D. Leslie

University of Manitoba

Publications: 40

Maria Luisa Brandi

Maria Luisa Brandi

University of Florence

Publications: 38

Ian R. Reid

Ian R. Reid

University of Auckland

Publications: 34

Andrea Giustina

Andrea Giustina

Vita-Salute San Raffaele University

Publications: 32

Tuan V. Nguyen

Tuan V. Nguyen

University of Technology Sydney

Publications: 31

Douglas P. Kiel

Douglas P. Kiel

Beth Israel Deaconess Medical Center

Publications: 31

Trending Scientists

Miroslav Trajkovic

Miroslav Trajkovic

Zebra Technologies (United States)

Alessandro S. Spinelli

Alessandro S. Spinelli

Polytechnic University of Milan

Cristina H. Amon

Cristina H. Amon

University of Toronto

Jun Ma

Jun Ma

Harbin Institute of Technology

Stephen J. Connon

Stephen J. Connon

Trinity College Dublin

Pedro Molina

Pedro Molina

University of Murcia

Tetsu Yonezawa

Tetsu Yonezawa

Hokkaido University

Vladan Stevanović

Vladan Stevanović

Colorado School of Mines

Kaoru Sugasawa

Kaoru Sugasawa

Kobe University

Drew J. Lyon

Drew J. Lyon

Washington State University

William B. Guggino

William B. Guggino

Johns Hopkins University

Jochen Hampe

Jochen Hampe

TU Dresden

Ruben Abagyan

Ruben Abagyan

University of California, San Diego

Miguel A. Alonso

Miguel A. Alonso

Spanish National Research Council

Frank Barry

Frank Barry

National University of Ireland, Galway

Jun Shimazaki

Jun Shimazaki

Tokyo Dental College

Something went wrong. Please try again later.